Sinusitis Treatment Market

Global sinusitis treatment market is likely to exhibit a promising growth curve as far as the short-term outlook is considered. The report will uncover the insights into how the market growth will unfold in the next few years.

Nasal Drug Delivery and Development of New Nasal Sprays to Gain Traction, Complementing Sinusitis Treatment Market Growth

Increasing prevalence of chronic rhinosinusitis (CRC) across the globe has paved attractive revenue opportunities for key players in the sinusitis treatment market. Drug manufacturing companies are tapping the incremental opportunities in CRS treatments by developing new solutions that facilitate enhanced intra nasal delivery of drugs. In addition, companies are also taking cues from innovations and are developing advanced drug delivery systems that help patients in treating themselves in home care settings thus reducing the burden of chronic sinusitis in the early stages. These research and development activities mainly aim to push the nasal sprays past the inflammation, thus improving the effectiveness of the drug. Development of new designs of nasal sprays has gained high traction in the sinusitis treatment market. For instance, XHANCE of Optinose has gained significant attention from patients as the spray can enter difficult to reach areas. Moreover, patients can use this nasal spray in their homes and with convenience. This is in view of eliminating the limitation of sprays of entering hard to reach cavities in the patients’ sinuses. This factor remains instrumental in complementing the growth of the sinusitis treatment market on the global front.

Rising Sales of Antibiotics to Largely Contribute Towards Revenue Growth of Sinusitis Treatment Market

The demand for antibiotics for the treatment of sinusitis has been on an upswing since past several years and is expected to maintain status quo going forward. This can be attributed towards fast paced lifestyle of individuals that has resulted in demand for quicker treatments of various diseases. In addition, increasing need for treating acute sinusitis among adults has triggered the research and development of advanced antibiotics. Over prescribing of antibiotics has resulted in an increase in pathogen resistance towards drugs which has caused an increase in the mortality and morbidity along with economic burden among patients. In view of this scenario, drug manufacturing companies are focusing on researching and developing novel antibiotics to treat sinus infection among patients. Given this background, antibiotics are gaining steam to treat bacterial sinusitis involving sphenoid, frontal and ethmoid sinuses. That said, antibiotics such as cephalosporins, penicillin and macrolides have witnessed higher demand, thus largely contributing towards value growth of the sinusitis treatment market among other alternative treatment options.

North America to Reign Supreme in Sinusitis Treatment Market, Asia Pacific to Reflect High Lucrativeness

Developed economies in North America are poised to showcase higher attractiveness apropos to the use of various treatment methods for sinusitis. This is mainly owing to increasing incidence of sinusitis in the region, particularly in the United States. For instance, according to CDC (Centers for Disease Control and Prevention), more than 28 million adults suffer from sinusitis every year. Similarly, according to ACCAI (American College of Allergy, Asthma and Immunology), individuals in the United States spend more than US$ 1 billion every year on OTC (Over the Counter) medications to treat sinusitis. As per ACCAI, sinus infection is a major health condition and is responsible for over 16 million physician visits in the country. Also, growing health awareness coupled with presence of major players has influenced the market growth. In addition, the outbreak of the COVID 19 pandemic further influenced the growth of the sinusitis treatment market in the region. In this backdrop, North America is expected to lead the market in terms of value in the forthcoming years. On the other side of the spectrum, emerging economies in Asia Pacific are likely to reflect high growth potential with regards to sinusitis treatment. This can be attributed towards several factors such as increasing number of sinus infected population backed by rising population, growing pharmaceutical sector, and rising awareness regarding severity of bacterial and respiratory diseases. Overall, the Asia Pacific is expected to open new avenues for companies in the sinusitis treatment market.

Sinusitis Treatment Market: Competitive Landscape

Major players in sinusitis treatment market have been involved in developing novel therapeutics to treat the disease. Also, increasing approvals for advanced medications from the Food and Drug Administration have aided the growth of the market worldwide. For instance, in August 2021, the Food and Drug Administration gave approval for GlaxoSmithKline’s Nucala (mepolizumab). Nucala is used for treating chronic rhinosinusitis with nasal polyps.

A few of the key players in global sinusitis treatment market include Olympus Corporation, Stryker Corporation, Medtronic PLC, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Sun Pharmaceutical Industries Inc., Sanofi, GlaxoSmithKline, Pfizer Inc., Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Abbott Laboratories, Wockhardt, Amneal Pharmaceuticals LLC, Bristol-Myers Squibb, AstraZeneca PLC, and Hikma Pharmaceuticals PLC.

The Global Sinusitis Treatment Market is Segmented as Below:

By Treatment Type

• Analgesics
• Antibiotics
  • Cephalosporin
  • Macrolide
  • Penicillin
• Antihistamines
• Surgery
  • Endoscopy
  • Balloon Sinusplasty
• Corticosteroids
• Sulphonamides
• Quinolones

By Disease Type

• Acute Sinusitis
• Sub-acute Sinusitis
• Chronic Sinusitis

By Distribution Channel

• Online Medical Pharmacies
• Retail Pharmacies
• Hospital Pharmacies

By Route of Administration

• Topical
• Nasal
• Injectable
• Oral

By Region

• North America

• U.S.
• Canada
• Mexico

• Europe

• UK
• France
• Germany
• Russia
• Rest of Europe

• Asia Pacific

• Japan
• South Korea
• India
• China
• Rest of Asia-Pacific

• LAMEA

• Latin America
• Middle East
• Africa

Key Elements Included In The Study: Global Sinusitis Treatment Market

• Sinusitis Treatment Market by Product/Technology/Grade, Application/End-user, and Region
• Executive Summary (Opportunity Analysis and Key Trends)
• Historical Market Size and Estimates, Value, 2018 - 2021
• Market Value at Regional and Country Level, 2022 - 2029
• Market Dynamics and Economic Overview
• Market Size in Value, Growth Rates, and Forecast Figures, 2022 - 2029
• Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
• Regional and Product/Grade/Application/End-user Price Trends Analysis
• Value Chain and Five Force’s Analysis
• Regional/Sub-region/Country Market Size and Trend Analysis
• Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

• The report will be prepared in a PPT format and will be delivered in a PDF format.

• Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.

• If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.

• If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.

• If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.

Disclaimer:

• The segmentation/company profiles/countries depicted above may vary in the actual report.